{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:13:42Z","timestamp":1784909622634,"version":"3.55.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aims to explore whether incorporating the triglyceride-glucose (TyG) index into the Framingham Risk Score (FRS) can enhance discriminative performance using raw data from the China Health and Nutrition Survey (CHNS) cohort, and to systematically quantify its incremental predictive value through a meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants were adults aged 45 to 80 years without baseline cardiovascular disease (CVD). Incident CVD was defined as new diagnoses of myocardial infarction or stroke. Cox regression was used to examine the association between TyG and CVD, and the results were expressed as hazard ratios (HR) with 95% confidence intervals (CI). While the incremental predictive value of TyG added to FRS was assessed via C-index, integrated discrimination improvement (IDI) and net reclassification improvement (NRI). Restricted cubic splines in Poisson models explored non-linearity. For the meta-analysis, we included effect estimates for the incremental value of the TyG index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The highest TyG quartile was significantly associated with higher risks of CVD (HR\u2009=\u20092.073; 95% CI: 1.233 to 3.488) and stroke (HR\u2009=\u20092.078; 95% CI: 1.428 to 5.521), with a non-linear dose-response relationship (\n                      <jats:italic>P<\/jats:italic>\n                      -nonlinear\u2009&amp;lt;\u20090.001). However, at the level of incremental predictive value, adding continuous TyG to FRS yielded a minimal C-index increase (from 0.731 to 0.732;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.559). Adding TyG quartiles improved some reclassification metrics (IDI and NRI) despite no significant C-index gain. Subgroup analyses showed no significant interactions. For the meta-analysis, Pooling five cohort studies (CVD incidence: 3.3% to 14.4%) demonstrated a minimal overall C-index gain of 0.0004 (95% CI: \u22120.0092 to 0.0100). Sensitivity analysis revealed that this result was heavily influenced by the Niloofar Barzegar 2020; its exclusion increased the pooled C-index gain to 0.0051 (95% CI: 0.0007 to 0.0094). According to the Grading of Recommendations Assessment, Development, and Evaluation framework, the overall certainty of evidence for the incremental C-index change was rated as very low.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While the TyG index shows a significant statistical association with CVD risk, its incremental predictive value beyond established FRS factors is minimal at the cohort level and negligible at the meta-analytic level. These findings suggest that the TyG index, despite being a significant risk marker, may not materially improve the predictive performance of existing cardiovascular risk scores.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1804411","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:02:51Z","timestamp":1784725371000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reassessing of the incremental predictive value of triglyceride-glucose index beyond traditional cardiovascular risk factors: a cohort study based on the China health and nutrition survey and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Fang","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Peking University Shougang Hospital","place":["Peking, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking University Shougang Hospital","place":["Peking, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking University Shougang Hospital","place":["Peking, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.jacc.2025.03.546","article-title":"10-Year and 30-year risks of cardiovascular disease in the U. S. Population","volume":"85","author":"Faridi","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics\u20142023 update: a report from the American heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham heart study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham heart study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement","volume":"328","author":"Mangione","year":"2022","journal-title":"J Am Med Assoc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/jama.2022.4983","article-title":"Aspirin use to prevent cardiovascular disease: US preventive services task force recommendation statement","volume":"327","author":"Davidson","year":"2022","journal-title":"J Am Med Assoc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"03000605231164548","DOI":"10.1177\/03000605231164548","article-title":"Insulin resistance and cardiovascular disease","volume":"51","author":"Kosmas","year":"2023","journal-title":"J Int Med Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2147\/RMHP.S352401","article-title":"Construction of a personalized insulin resistance risk assessment tool in Xinjiang Kazakhs based on lipid- and obesity-related indices","volume":"15","author":"Yu","year":"2022","journal-title":"Risk Manag Healthc Policy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"S0953-6205(24)00375\u20133","DOI":"10.1016\/j.ejim.2024.08.026","article-title":"Triglyceride glucose (TyG) index: a promising biomarker for diagnosis and treatment of different diseases","volume":"131","author":"Sun","year":"2024","journal-title":"Eur J Intern Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40001-024-01728-4","article-title":"Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan cohort study (ICS)","volume":"29","author":"Rafiee","year":"2024","journal-title":"Eur J Med Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-022-01593-7","article-title":"High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study","volume":"21","author":"Xu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","article-title":"Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data","volume":"22","author":"Che","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/ije\/dyp322","article-title":"Cohort profile: the China health and nutrition survey\u2013monitoring and understanding socio-economic and health change in China, 1989-2011","volume":"39","author":"Popkin","year":"2010","journal-title":"Int J Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/obr.12119","article-title":"The China health and nutrition survey, 1989-2011","volume":"15","author":"Zhang","year":"2014","journal-title":"Obes Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update: a report from the American heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.numecd.2024.07.002","article-title":"Higher egg consumption and incident cardiovascular disease in Chinese adults - 10-year follow-up results from China health and nutrition survey","volume":"34","author":"Yakti","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41430-020-0668-6","article-title":"Dietary patterns and cardiovascular disease risk among Chinese adults: a prospective cohort study","volume":"74","author":"Shi","year":"2020","journal-title":"Eur J Clin Nutr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"B21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/978-0-387-77244-8","volume-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating","author":"Steyerberg","year":"2009"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1002\/sim.7286","article-title":"Event rate net reclassification index and the integrated discrimination improvement for studying incremental value of risk markers","volume":"36","author":"Van Smeden","year":"2017","journal-title":"Stat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.7326\/0003-4819-156-6-201203200-00006","article-title":"Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study","volume":"156","author":"Kavousi","year":"2012","journal-title":"Ann Intern Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/postmj\/qgaf033","article-title":"The role of cardiovascular health in the associations between insulin resistance, future cardiovascular disease, and all-cause mortality","volume":"101","author":"Qiu","year":"2025","journal-title":"Postgrad Med J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-020-01121-5","article-title":"The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran lipid and glucose study","volume":"19","author":"Barzegar","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/eci.12583","article-title":"The TyG index may predict the development of cardiovascular events","volume":"46","author":"S\u00e1nchez-\u00cd\u00f1igo","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3760\/cma.j.cn112150-20210616-00593","article-title":"[The relationship between triglyceride glucose index and risk of cardiovascular disease among Kazakh and Uygur population in Xinjiang: a retrospective cohort analysis]","volume":"56","author":"Yu","year":"2022","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"B30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41569-019-0202-5","article-title":"70-Year legacy of the Framingham heart study","volume":"16","author":"Andersson","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1161\/CIRCULATIONAHA.121.057889","article-title":"Temporal trends in the remaining lifetime risk of cardiovascular disease among middle-aged adults across 6 decades: the Framingham study","volume":"145","author":"Vasan","year":"2022","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/eurheartj\/ehad539","article-title":"Recommendations for statin management in primary prevention: disparities among international risk scores","volume":"45","author":"Mancini","year":"2024","journal-title":"Eur Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metab Clin Exp"},{"key":"B35","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","article-title":"Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome","volume":"32","author":"Son","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"109042","DOI":"10.1016\/j.diabres.2021.109042","article-title":"The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance","volume":"180","author":"Park","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations","volume":"21","author":"Tao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"110891","DOI":"10.1016\/j.clinbiochem.2025.110891","article-title":"Assessing the predictive value of elevated triglycerides, triglyceride-glucose index (TyG), and TG\/HDL ratios for cardiovascular disease and mortality during 20 years of follow-up: Tehran lipid and glucose study","volume":"136","author":"Khalili","year":"2025","journal-title":"Clin Biochem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3803\/EnM.2024.2205","article-title":"Association between the triglyceride-glucose index and cardiovascular risk and mortality across different diabetes durations: a nationwide cohort study","volume":"40","author":"Kwak","year":"2025","journal-title":"Endocrinol Metab Seoul Korea"},{"key":"B40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1101\/2022.06.28.22277033","article-title":"Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a Mendelian randomization analysis","volume":"21","author":"Li","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1038\/s41598-023-46983-3","article-title":"Mendelian randomization study on insulin resistance and risk of hypertension and cardiovascular disease","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","article-title":"Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","article-title":"Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12872-020-01768-8","article-title":"Estimate of prevalent ischemic stroke from triglyceride glucose-body mass index in the general population","volume":"20","author":"Du","year":"2020","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1804411\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:51:24Z","timestamp":1784908284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1804411\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":44,"alternative-id":["10.3389\/fcvm.2026.1804411"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1804411","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1804411"}}